AUM $8.00BER 0.44%NAV $170.10Holdings 251Inception Feb 2001
Price Chart
Key Statistics
Previous Close
$170.00Day Range
$169.95$172.79
52-Week Range
$116.92$177.64
Avg Volume
1.4MDividend Yield
0.23%Expense Ratio
0.44%AUM
$8.00BShares Outstanding
47.0METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 87.42% |
| Netherlands | 3.82% |
| Denmark | 2.15% |
| United Kingdom | 1.76% |
| Canada | 0.94% |
| Germany | 0.70% |
| Ireland | 0.67% |
| Other | 0.61% |
| France | 0.55% |
| Switzerland | 0.48% |
| China | 0.16% |
| Jersey | 0.15% |
| Singapore | 0.10% |
| Belgium | 0.10% |
| Spain | 0.10% |
| Australia | 0.09% |
| Italy | 0.08% |
| Cayman Islands | 0.07% |
| Iceland | 0.04% |
| Taiwan (Province of China) | 0.01% |
Fund Information
- Issuer
- iShares
- Category
- Healthcare
- Types
- Biotech
- Inception Date
- Feb 5, 2001
- Exchange
- NASDAQ
- Description
- The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Similar ETFs
The iShares Biotechnology ETF (IBB) is an exchange-traded fund issued by iShares that launched on Feb 5, 2001. It currently manages $8.00B in assets under management. The fund charges an expense ratio of 0.44%. The fund holds 251 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 45.1% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | GILD | GILEAD SCIENCES INC | 7.42% | 4,454,136 | $594.5M |
| 2 | VRTX | VERTEX PHARMACEUTICALS INC | 7.07% | 1,335,351 | $566.7M |
| 3 | AMGN | AMGEN INC | 7.03% | 1,709,200 | $563.3M |
| 4 | REGN | REGENERON PHARMACEUTICALS INC | 6.55% | 747,526 | $525.0M |
| 5 | ALNY | ALNYLAM PHARMACEUTICALS INC | 3.63% | 965,745 | $290.8M |
| 6 | ARGX | ARGENX SE ADR | 3.34% | 336,749 | $267.6M |
| 7 | INSM | INSMED INC | 2.72% | 1,565,370 | $218.3M |
| 8 | BIIB | BIOGEN INC | 2.54% | 1,075,692 | $203.4M |
| 9 | NTRA | NATERA INC | 2.50% | 966,795 | $199.9M |
| 10 | RVMD | REVOLUTION MEDICINES INC | 2.33% | 1,265,426 | $186.3M |
| 11 | UTHR | UNITED THERAPEUTICS CORP | 2.22% | 311,015 | $178.0M |
| 12 | ONC | BEONE MEDICINES AG | 1.94% | 521,766 | $155.2M |
| 13 | ILMN | ILLUMINA INC | 1.90% | 1,091,694 | $151.8M |
| 14 | INCY | INCYTE CORP | 1.76% | 1,447,092 | $141.0M |
| 15 | MRNA | MODERNA INC | 1.55% | 2,653,686 | $124.0M |
Page 1 of 6
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +1.28% | |
| 1W | +1.14% | |
| 1M | +0.05% | |
| 3M | +0.96% | |
| 6M | +4.93% | |
| YTD | +1.94% | |
| 1Y | +44.13% | |
| 3Y | +30.77% | |
| 5Y | +15.10% |
Moving Averages
20-Day MA
$171.35
Above 20-Day MA50-Day MA
$169.22
Above 50-Day MA200-Day MA
$159.82
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$177.64
Current Price
$172.16
52-Week Low
$116.92
$116.92$177.64
Current Yield
0.23%
Annual Dividend
$0.4495
Frequency
4x/year
Last Ex-Date
Dec 16, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $0.1831 | Dec 19, 2025 |
| Sep 16, 2025 | $0.0828 | Sep 19, 2025 |
| Mar 18, 2025 | $0.1212 | Mar 21, 2025 |
| Dec 17, 2024 | $0.0624 | Dec 20, 2024 |
| Sep 25, 2024 | $0.2005 | Sep 30, 2024 |
| Mar 21, 2024 | $0.1260 | Mar 27, 2024 |
| Dec 20, 2023 | $0.1240 | Dec 27, 2023 |
| Sep 26, 2023 | $0.1532 | Oct 2, 2023 |
| Jun 7, 2023 | $0.0062 | Jun 13, 2023 |
| Mar 23, 2023 | $0.0646 | Mar 29, 2023 |
| Dec 13, 2022 | $0.1014 | Dec 19, 2022 |
| Sep 26, 2022 | $0.1586 | Sep 30, 2022 |
| Jun 9, 2022 | $0.0305 | Jun 15, 2022 |
| Mar 24, 2022 | $0.1176 | Mar 30, 2022 |
| Dec 13, 2021 | $0.0413 | Dec 17, 2021 |
| Sep 24, 2021 | $0.1244 | Sep 30, 2021 |
| Jun 10, 2021 | $0.0232 | Jun 16, 2021 |
| Mar 25, 2021 | $0.1311 | Mar 31, 2021 |
| Dec 14, 2020 | $0.0655 | Dec 18, 2020 |
| Sep 23, 2020 | $0.0632 | Sep 29, 2020 |
Dividend Payments Over Time
Category Comparison
| Metric | IBB | Healthcare(207 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.44% | 0.60% | 0.83% |
| AUM | $8.00B | $1.23B | $1.46B |
| Dividend Yield | 0.23% | 3.25% | 1.97% |
| Avg Volume | 1.4M | 362.5K | 739.7K |
| Holdings | 251 | 177 | 66 |
| Performance | |||
| 1-Month Return | +0.05% | +2.59% | +2.08% |
| 6-Month Return | +9.23% | +8.69% | +9.81% |
| YTD Return | +2.08% | +3.85% | +1.82% |
| 1-Year Return | +47.72% | +31.19% | +49.59% |
Compare with Another ETF
Search for an ETF to compare with IBB:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.